Interestingly, Yanguas et al. showed that in a mouse model of melanoma, increased number of intra-tumorally injected tumor-specific T cells migrated into the draining lymph nodes in mice treated with anti-ICAM-1 or anti-LFA-1 mAbs compared to mice treated with control IgG (134). This evidence concerns the gene ICAM1 and melanoma.